# Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma

> **NCT01333709** · PHASE2 · COMPLETED · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 150 (actual)

## Conditions studied

- Locally Advanced Malignant Neoplasm
- Rectal Carcinoma

## Interventions

- **DRUG:** Induction trichemotherapy - FOLFIRINOX regimen
- **OTHER:** Early tumor response evaluation by MRI volumetry
- **RADIATION:** Radiochemotherapy Cap 50
- **RADIATION:** Radiochemotherapy Cap 60
- **PROCEDURE:** Radical proctectomy with total mesorectal excision

## Key facts

- **NCT ID:** NCT01333709
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01333709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01333709, "Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01333709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*